What is Vasorum?
Founded in 2005, Vasorum operates within the medical device industry, focusing on the development and manufacturing of vascular closure devices. These devices are critical for procedures requiring access to blood vessels, aiming to improve patient outcomes and streamline clinical workflows. The company's strategic location in Dublin, Ireland, positions it within a robust European hub for medical technology innovation and manufacturing. Vasorum's commitment to advancing vascular access technology is a key differentiator in its market.
How much funding has Vasorum raised?
Vasorum has raised a total of $7.3M across 1 funding round:
Stock Offering
$7.3M
Stock Issuance/Offering (2021): $7.3M with participation from Business Growth Fund
Key Investors in Vasorum
Business Growth Fund
BGF, headquartered in London, United Kingdom, is the most active and influential investor in small and mid-sized businesses in the UK. An established and independent company, it supports a range of growing companies - early stage, growth stage, and quoted - across every region and sector of the economy.
What's next for Vasorum?
The recent major strategic investment signals a pivotal moment for Vasorum, likely enabling the company to scale its operations, enhance its product portfolio, and broaden its market reach. With a total funding base of $7.3M, Vasorum is well-positioned to navigate the complexities of the medical device industry, potentially pursuing further research and development, expanding its sales and distribution networks, and exploring strategic partnerships. The company's focus on vascular closure devices suggests a strategic intent to capture a significant share of this specialized medical market.
See full Vasorum company page
